Seccia TM, Caroccia B and Calò LA: Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms. J Hypertens. 35:205–212. 2017. View Article : Google Scholar : PubMed/NCBI

Hart PD and Bakris GL: Hypertensive nephropathy: Prevention and treatment recommendations. Expert Opin Pharmacother. 11:2675–2686. 2010. View Article : Google Scholar : PubMed/NCBI

Damkjær M, Isaksson GL, Stubbe J, Jensen BL, Assersen K and Bie P: Renal renin secretion as regulator of body fluid homeostasis. Pflugers Arch. 465:153–165. 2013. View Article : Google Scholar : PubMed/NCBI

Huang QF, Hoshide S, Cheng HM, Park S, Park CG, Chen CH, Kario K and Wang JG; Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group(COME Asia MHDG), : Management of hypertension in patients with chronic kidney disease in Asia. Curr Hypertens Rev. 12:181–185. 2016. View Article : Google Scholar : PubMed/NCBI

Lu X and Crowley SD: Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 20:1032018. View Article : Google Scholar : PubMed/NCBI

Guan Z, Makled MN and Inscho EW: Purinoceptors, renal microvascular function and hypertension. Physiol Res. 69:353–369. 2020. View Article : Google Scholar : PubMed/NCBI

Freedman BI and Cohen AH: Hypertension-attributed nephropathy: What's in a name? Nat Rev Nephrol. 12:27–36. 2016. View Article : Google Scholar : PubMed/NCBI

Kandasamy Y, Watson D and Rudd D: Biomarker of early glomerular injury in pre-eclampsia. Hypertens Pregnancy. 34:391–399. 2015. View Article : Google Scholar : PubMed/NCBI

Meier P: Atherosclerotic renal artery stenosis: Update on management strategies. Curr Opin Cardiol. 26:463–471. 2011. View Article : Google Scholar : PubMed/NCBI

Rodriguez-Iturbe B and Johnson RJ: The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension. Hypertens Res. 33:975–980. 2010. View Article : Google Scholar : PubMed/NCBI

Textor SC and Lerman L: Renovascular hypertension and ischemic nephropathy. Am J Hypertens. 23:1159–1169. 2010. View Article : Google Scholar : PubMed/NCBI

Udani S, Lazich I and Bakris GL: Epidemiology of hypertensive kidney disease. Nat Rev Nephrol. 7:11–21. 2011. View Article : Google Scholar : PubMed/NCBI

Sun HJ: current opinion for hypertension in renal fibrosis. Adv Exp Med Biol. 1165:37–47. 2019. View Article : Google Scholar : PubMed/NCBI

Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, et al: Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis. Lancet. 387:435–443. 2016. View Article : Google Scholar : PubMed/NCBI

Romero CA and Carretero OA: Tubule-vascular feedback in renal autoregulation. Am J Physiol Renal Physiol. 316:F1218–F1226. 2019. View Article : Google Scholar : PubMed/NCBI

Satou R, Shao W and Navar LG: Role of stimulated intrarenal angiotensinogen in hypertension. Ther Adv Cardiovasc Dis. 9:181–190. 2015. View Article : Google Scholar : PubMed/NCBI

Lau WL, Huisa BN and Fisher M: the cerebrovascular-chronic kidney disease connection: Perspectives and mechanisms. Transl Stroke Res. 8:67–76. 2017. View Article : Google Scholar : PubMed/NCBI

Ihm CG: Hypertension in chronic glomerulonephritis. Electrolyte Blood Press. 13:41–45. 2015. View Article : Google Scholar : PubMed/NCBI

Hughson MD, Puelles VG, Hoy WE, Douglas-Denton RN, Mott SA and Bertram JF: Hypertension, glomerular hypertrophy and nephrosclerosis: The effect of race. Nephrol Dial Transplant. 29:1399–1409. 2014. View Article : Google Scholar : PubMed/NCBI

D'Elia JA, Bayliss G, Gleason RE and Weinrauch LA: Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: A review. Clin Kidney J. 9:705–712. 2016. View Article : Google Scholar : PubMed/NCBI

Simeoni M, Armeni A, Summaria C, Cerantonio A and Fuiano G: Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney. Ren Fail. 39:660–670. 2017. View Article : Google Scholar : PubMed/NCBI

Campese VM, Mitra N and Sandee D: Hypertension in renal parenchymal disease: Why is it so resistant to treatment? Kidney Int. 69:967–973. 2006. View Article : Google Scholar : PubMed/NCBI

Heyman SN, Khamaisi M, Rosen S and Rosenberger C: Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol. 28:998–1006. 2008. View Article : Google Scholar : PubMed/NCBI

Lerman LO, Textor SC and Grande JP: Mechanisms of tissue injury in renal artery stenosis: Ischemia and beyond. Prog Cardiovasc Dis. 52:196–203. 2009. View Article : Google Scholar : PubMed/NCBI

Zeng Y, Wang X, Xie F and Zheng Z: Ischemia-induced glomerular parietal epithelial cells hyperplasia: Commonly misdiagnosed cellular crescent in renal biopsy. Pathol Res Pract. 213:982–986. 2017. View Article : Google Scholar : PubMed/NCBI

Nicolosi PA, Tombetti E, Maugeri N, Rovere-Querini P, Brunelli S and Manfredi AA: Vascular remodelling and mesenchymal transition in systemic sclerosis. Stem Cells Int. 2016:46368592016. View Article : Google Scholar : PubMed/NCBI

Rodriguez-Iturbe B, Pons H and Johnson RJ: Role of the immune system in hypertension. Physiol Rev. 97:1127–1164. 2017. View Article : Google Scholar : PubMed/NCBI

Frame AA and Wainford RD: Mechanisms of altered renal sodium handling in age-related hypertension. Am J Physiol Renal Physiol. 315:F1–F6. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang C, Booz GW, Yu Q, He X, Wang S and Fan F: Conflicting roles of 20-HETE in hypertension and renal end organ damage. Eur J Pharmacol. 833:190–200. 2018. View Article : Google Scholar : PubMed/NCBI

Mendoza-Torres E, Oyarzún A, Mondaca-Ruff D, Azocar A, Castro PF, Jalil JE, Chiong M, Lavandero S and Ocaranza MP: ACE2 and vasoactive peptides: Novel players in cardiovascular/renal remodeling and hypertension. Ther Adv Cardiovasc Dis. 9:217–237. 2015. View Article : Google Scholar : PubMed/NCBI

Laurent S and Boutouyrie P: The structural factor of hypertension: Large and small artery alterations. Circ Res. 116:1007–1021. 2015. View Article : Google Scholar : PubMed/NCBI

Miyagawa K and Emoto N: Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension. Ther Adv Cardiovasc Dis. 8:202–216. 2014. View Article : Google Scholar : PubMed/NCBI

Povlsen AL, Grimm D, Wehland M, Infanger M and Krüger M: The vasoactive mas receptor in essential hypertension. J Clin Med. 9:2672020. View Article : Google Scholar

Tracy RE: Renal vasculature in essential hypertension: A review of some contrarian evidence. Contrib Nephrol. 169:327–336. 2011. View Article : Google Scholar : PubMed/NCBI

Brown IAM, Diederich L, Good ME, DeLalio LJ, Murphy SA, Cortese-Krott MM, Hall JL, Le TH and Isakson BE: Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension. Arterioscler Thromb Vasc Biol. 38:1969–1985. 2018. View Article : Google Scholar : PubMed/NCBI

Li Q, Youn JY and Cai H: Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens. 33:1128–1136. 2015. View Article : Google Scholar : PubMed/NCBI

Xu M, Lu YP, Hasan AA and Hocher B: Plasma ET-1 concentrations are elevated in patients with hypertension-meta-analysis of clinical studies. Kidney Blood Press Res. 42:304–313. 2017. View Article : Google Scholar : PubMed/NCBI

Versmissen J, Mirabito Colafella KM, Koolen SLW and Danser AHJ: Vascular cardio-oncology: Vascular endothelial growth factor inhibitors and hypertension. Cardiovasc Res. 115:904–914. 2019. View Article : Google Scholar : PubMed/NCBI

Wu J, Agbor LN, Fang S, Mukohda M, Nair AR, Nakagawa P, Sharma A, Morgan DA, Grobe JL, Rahmouni K, et al: Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension. Cardiovasc Res. 117:308–319. 2021. View Article : Google Scholar : PubMed/NCBI

Hill GS: Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 17:266–270. 2008. View Article : Google Scholar : PubMed/NCBI

Zhang L, Yang L, Shergis J, Zhang L, Zhang AL, Guo X, Qin X, Johnson D, Liu X, Lu C, et al: Chinese herbal medicine for diabetic kidney disease: A systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open. 9:e0256532019. View Article : Google Scholar : PubMed/NCBI

Ren W, Liao J, Chen J, Li Z and Huang L: The effect of Chinese herbal medicine combined with western medicine on vascular endothelial function for patients with hypertension: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 98:e181342019. View Article : Google Scholar : PubMed/NCBI

Wang J, Qin T, Chen J, Li Y, Wang L, Huang H and Li J: Hyperuricemia and risk of incident hypertension: A systematic review and meta-analysis of observational studies. PLoS One. 9:e1142592014. View Article : Google Scholar : PubMed/NCBI

Gao X, Peleli M, Zollbrecht C, Patzak A, Persson AE and Carlström M: Adenosine A1 receptor-dependent and independent pathways in modulating renal vascular responses to angiotensin II. Acta Physiol (Oxf). 213:268–276. 2015. View Article : Google Scholar : PubMed/NCBI

Pojoga LH, Yao TM, Opsasnick LA, Siddiqui WT, Reslan OM, Adler GK, Williams GH and Khalil RA: Cooperative role of mineralocorticoid receptor and caveolin-1 in regulating the vascular response to low nitric oxide-high angiotensin II-induced cardiovascular injury. J Pharmacol Exp Ther. 355:32–47. 2015. View Article : Google Scholar : PubMed/NCBI

Yu D, Shi M, Bao J, Yu X, Li Y and Liu W: Genipin ameliorates hypertension-induced renal damage via the angiotensin II-TLR/MyD88/MAPK pathway. Fitoterapia. 112:244–253. 2016. View Article : Google Scholar : PubMed/NCBI

Zhang SF, Mao XJ, Jiang WM and Fang ZY: Qian Yang Yu Yin Granule protects against hypertension-induced renal injury by epigenetic mechanism linked to nicotinamide N-methyltransferase (NNMT) expression. J Ethnopharmacol. 255:1127382020. View Article : Google Scholar : PubMed/NCBI

Han L, Ma Y, Qin JG, Li LN, Gao YS, Zhang XY, Guo Y, Song LM, Luo YN and Chi XY: The renal protective effect of Jiangya tongluo formula, through regulation of adrenomedullin and angiotensin II, in rats with hypertensive nephrosclerosis. Evid Based Complement Alternat Med. 2015:4281062015. View Article : Google Scholar : PubMed/NCBI

Tian D, Ling S, Chen G, Li Y, Liu J, Ferid M and Bian K: Hypertensive nephropathy treatment by heart-protecting musk pill: A study of anti-inflammatory therapy for target organ damage of hypertension. Int J Gen Med. 4:131–139. 2011.PubMed/NCBI

Chen YH, Lei SS, Li B, Luo R, He X, Wang YZ, Zhou FC, Lv GY and Chen SH: Systematic understanding of the mechanisms of flos chrysanthemi indici-mediated effects on hypertension via computational target fishing. Comb Chem High Throughput Screen. 23:92–110. 2020. View Article : Google Scholar : PubMed/NCBI

Limón RI, Peñas E, Martínez-Villaluenga C and Frias J: Role of elicitation on the health-promoting properties of kidney bean sprouts. LWT Food Sci Technol. 56:328–334. 2014. View Article : Google Scholar

Chen H, Wang MC, Chen YY, Chen L, Wang YN, Vaziri ND, Miao H and Zhao YY: Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis. Ther Adv Chronic Dis. 11:20406223209200252020. View Article : Google Scholar : PubMed/NCBI

Chen L, Chen DQ, Wang M, Liu D, Chen H, Dou F, Vaziri ND and Zhao YY: Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy. Chem Biol Interact. 273:56–72. 2017. View Article : Google Scholar : PubMed/NCBI

Wang M, Chen DQ, Wang MC, Chen H, Chen L, Liu D, Zhao H and Zhao YY: Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway. Phytomedicine. 36:243–253. 2017. View Article : Google Scholar : PubMed/NCBI

Wang M, Chen DQ, Chen L, Liu D, Zhao H, Zhang ZH, Vaziri ND, Guo Y, Zhao YY and Cao G: Novel RAS inhibitors poricoic acid ZG and poricoic acid ZH attenuate renal fibrosis via a Wnt/β-catenin pathway and targeted phosphorylation of Smad3 signaling. J Agric Food Chem. 66:1828–1842. 2018. View Article : Google Scholar : PubMed/NCBI

Wang M, Chen DQ, Chen L, Cao G, Zhao H, Liu D, Vaziri ND, Guo Y and Zhao YY: Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. Br J Pharmacol. 175:2689–2708. 2018. View Article : Google Scholar : PubMed/NCBI

Chen H, Yang T, Wang MC, Chen DQ, Yang Y and Zhao YY: Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Phytomedicine. 42:207–218. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang CC, Gu WL, Wu XM, Li YM, Chen CX and Huang XY: Active components from Radix scrophulariae inhibits the ventricular remodeling induced by hypertension in rats. Springerplus. 5:3582016. View Article : Google Scholar : PubMed/NCBI

Lian FZ, Cheng P, Ruan CS, Ling XX, Wang XY, Pan M, Chen ML, Shen AZ and Gao S: Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats. Biomed Pharmacother. 117:1091242019. View Article : Google Scholar : PubMed/NCBI

Yang T, Chen YY, Liu JR, Zhao H, Vaziri ND, Guo Y and Zhao YY: Natural products against renin-angiotensin system for antifibrosis therapy. Eur J Med Chem. 179:623–633. 2019. View Article : Google Scholar : PubMed/NCBI

Deng YF, Aluko RE, Jin Q, Zhang Y and Yuan LJ: Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm Biol. 50:401–406. 2012. View Article : Google Scholar : PubMed/NCBI

Lv GY, Zhang YP, Gao JL, Yu JJ, Lei J, Zhang ZR, Li B, Zhan RJ and Chen SH: Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats. J Ethnopharmacol. 150:507–513. 2013. View Article : Google Scholar : PubMed/NCBI

Zhao YY, Li HT, Feng YL, Bai X and Lin RC: Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats. J Ethnopharmacol. 148:403–410. 2013. View Article : Google Scholar : PubMed/NCBI

Zheng X, Wang S, Zou X, Jing Y, Yang R, Li S and Wang F: Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Exp Anim. 66:217–228. 2017. View Article : Google Scholar : PubMed/NCBI

Kaiser S, Carvalho ÂR, Pittol V, Dietrich F, Manica F, Machado MM, de Oliveira LF, Oliveira Battastini AM and Ortega GG: Genotoxicity and cytotoxicity of oxindole alkaloids from Uncaria tomentosa (cat's claw): Chemotype relevance. J Ethnopharmacol. 189:90–98. 2016. View Article : Google Scholar : PubMed/NCBI

Zhang RH, Liu ZK, Yang DS, Zhang XJ, Sun HD and Xiao WL: Phytochemistry and pharmacology of the genus leonurus: The herb to benefit the mothers and more. Phytochemistry. 147:167–183. 2018. View Article : Google Scholar : PubMed/NCBI

Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, Rizzoni D, Rossignol P, Ruilope LM, van den Meiracker AH, et al: Endothelial factors in the pathogenesis and treatment of chronic kidney disease part I: General mechanisms: A joint consensus statement from the European society of hypertension working group on endothelin and endothelial factors and the Japanese society of hypertension. J Hypertens. 36:451–461. 2018. View Article : Google Scholar : PubMed/NCBI

Brusilovskaya K, Königshofer P, Schwabl P and Reiberger T: Vascular targets for the treatment of portal hypertension. Semin Liver Dis. 39:483–501. 2019. View Article : Google Scholar : PubMed/NCBI

Westfall TC, Macarthur H, Byku M, Yang CL and Murray J: Interactions of neuropeptide y, catecholamines, and angiotensin at the vascular neuroeffector junction. Adv Pharmacol. 68:115–139. 2013. View Article : Google Scholar : PubMed/NCBI

Zhu X, Zhou Z, Zhang Q, Cai W, Zhou Y, Sun H and Qiu L: Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats. J Cell Biochem. 119:926–937. 2018. View Article : Google Scholar : PubMed/NCBI

Jiang P, Ma D, Wang X, Wang Y, Bi Y, Yang J, Wang X and Li X: Astragaloside IV prevents obesity-associated hypertension by improving pro-inflammatory reaction and leptin resistance. Mol Cells. 41:244–255. 2018.PubMed/NCBI

Wang YC, Ma DF, Jiang P, Zhang YM, Zhou GF, Yang JL, Li ZY and Li X: Guizhi decoction () inhibits cholinergic transdifferentiation by regulating imbalance of NGF and LIF in salt-sensitive hypertensive heart failure rats. Chin J Integr Med. 26:188–196. 2020. View Article : Google Scholar : PubMed/NCBI

Xiong W, He FF, You RY, Xiong J, Wang YM, Zhang C, Meng XF and Su H: Acupuncture application in chronic kidney disease and its potential mechanisms. Am J Chin Med. 46:1169–1185. 2018. View Article : Google Scholar : PubMed/NCBI

Paterno JC, Bergamaschi CT, Campos RR, Higa EM, Soares MF, Schor N, Freire AO and Teixeira VP: Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats. Kidney Blood Press Res. 35:355–364. 2012. View Article : Google Scholar : PubMed/NCBI

Yang JW, Ye Y, Wang XR, Li F, Xiao LY, Shi GX and Liu CZ: Acupuncture attenuates renal sympathetic activity and blood pressure via beta-adrenergic receptors in spontaneously hypertensive rats. Neural Plast. 2017:86964022017. View Article : Google Scholar : PubMed/NCBI

Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C and Volpe M: Hypertension and kidneys: Unraveling complex molecular mechanisms underlying hypertensive renal damage. J Hum Hypertens. 28:74–79. 2014. View Article : Google Scholar : PubMed/NCBI

Crowley SD: The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal. 20:102–120. 2014. View Article : Google Scholar : PubMed/NCBI

Zhang J, An SJ, Fu JQ, Liu P, Shao TM, Li M, Li X, Jiao Z and Chai XQ: Mixed aqueous extract of Salvia miltiorrhiza reduces blood pressure through inhibition of vascular remodelling and oxidative stress in spontaneously hypertensive rats. Cell Physiol Biochem. 40:347–360. 2016. View Article : Google Scholar : PubMed/NCBI

Li Y, Huang C, Fu W, Zhang H, Lao Y, Zhou H, Tan H and Xu H: Screening of the active fractions from the Coreopsis tinctoria nutt. Flower on diabetic endothelial protection and determination of the underlying mechanism. J Ethnopharmacol. 253:1126452020. View Article : Google Scholar : PubMed/NCBI

Teles F, da Silva TM, da Cruz Júnior FP, Honorato VH, de Oliveira Costa H, Barbosa AP, de Oliveira SG, Porfírio Z, Libório AB, Borges RL and Fanelli C: Brazilian red propolis attenuates hypertension and renal damage in 5/6 renal ablation model. PLoS One. 10:e01165352015. View Article : Google Scholar : PubMed/NCBI

Guo H, Kuang Z, Zhang J, Zhao X, Pu P and Yan J: The preventive effect of Apocynum venetum polyphenols on D-galactose-induced oxidative stress in mice. Exp Ther Med. 19:557–568. 2020.PubMed/NCBI

Moodley K, Naidoo Y and Mackraj I: Effects of Tulbaghia violacea Harv. (Alliaceae) rhizome methanolic extract on kidney function and morphology in Dahl salt-sensitive rats. J Ethnopharmacol. 155:1194–1203. 2014. View Article : Google Scholar : PubMed/NCBI

Hamza SM and Dyck JR: Systemic and renal oxidative stress in the pathogenesis of hypertension: Modulation of long-term control of arterial blood pressure by resveratrol. Front Physiol. 5:2922014. View Article : Google Scholar : PubMed/NCBI

Zhu J, Zhang Y and Yang C: Protective effect of 3-n-butylphthalide against hypertensive nephropathy in spontaneously hypertensive rats. Mol Med Rep. 11:1448–1454. 2015. View Article : Google Scholar : PubMed/NCBI

Lin F, Huang X, Xing F, Xu L, Zhang W, Chen Z, Ke X, Song Y and Zeng Z: Semen brassicae reduces thoracic aortic remodeling, inflammation, and oxidative damage in spontaneously hypertensive rats. Biomed Pharmacother. 129:1104002020. View Article : Google Scholar : PubMed/NCBI

Gai Z, Wang Z, Zhang L, Ma J and Zhu Q: Paeonol protects against hypertension in spontaneously hypertensive rats by restoring vascular endothelium. Biosci Biotechnol Biochem. 83:1992–1999. 2019. View Article : Google Scholar : PubMed/NCBI

Lu H, Yao H, Zou R, Chen X and Xu H: Galangin suppresses renal inflammation via the inhibition of NF-κB, PI3K/AKT and NLRP3 in uric acid treated NRK-52E tubular epithelial cells. Biomed Res Int. 2019:30183572019. View Article : Google Scholar : PubMed/NCBI

Dong H, Ming S, Fang J, Li Y and Liu L: Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation. Hum Cell. 32:22–30. 2019. View Article : Google Scholar : PubMed/NCBI

Yan D, Yue B, Qian M, Zhao L, Zhang Z, Qian H, Yan S, Qian Y and Fang Z: JYYS granule mitigates renal injury in clinic and in spontaneously hypertensive rats by inhibiting NF-κB signaling-mediated microinflammation. Evid Based Complement Alternat Med. 2018:84729632018. View Article : Google Scholar : PubMed/NCBI

Luo WM, Kong J, Gong Y, Liu XQ, Yang RX and Zhao YX: Tongxinluo protects against hypertensive kidney injury in spontaneously-hypertensive rats by inhibiting oxidative stress and activating forkhead box o1 signaling. PLoS One. 10:e01451302015. View Article : Google Scholar : PubMed/NCBI

Jiang J, Huang D, Li Y, Gan Z, Li H, Li X, Bian K and Ke Y: Heart protection by herb formula BanXia BaiZhu TianMa decoction in spontaneously hypertensive rats. Evid Based Complement Alternat Med. 2019:56129292019. View Article : Google Scholar : PubMed/NCBI

Ding K, Wang Y, Jiang W, Zhang Y, Yin H and Fang Z: Qian Yang Yu Yin Granule-containing serum inhibits angiotensin II-induced proliferation, reactive oxygen species production, and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway. BMC Complement Altern Med. 15:812015. View Article : Google Scholar : PubMed/NCBI

Lu L, Sun X, Chen C, Qin Y and Guo X: Shexiang baoxin pill, derived from the traditional Chinese medicine, provides protective roles against cardiovascular diseases. Front Pharmacol. 9:11612018. View Article : Google Scholar : PubMed/NCBI

Wang XY, Huang GY, Lian FZ, Pan M, Ruan CS, Ling XX, Chen ML, Shen AZ and Gao S: Protective effect of Xin-Ji-Er-Kang on cardiovascular remodeling in high-salt induced hypertensive mice: Role ofoxidative stress and endothelial dysfunction. Biomed Pharmacother. 115:1089372019. View Article : Google Scholar : PubMed/NCBI

Guo K, Lan CZ, Yu TT, Huang LL, Wang XH, Pan C and Gao S: Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats. J Ethnopharmacol. 155:1227–1235. 2014. View Article : Google Scholar : PubMed/NCBI

Yu TT, Guo K, Chen HC, Lan CZ, Wang J, Huang LL, Wang XH, Zhang Z and Gao S: Effects of traditional Chinese medicine Xin-Ji-Er-Kang formula on 2K1C hypertensive rats: Role of oxidative stress and endothelial dysfunction. BMC Complement Altern Med. 13:1732013. View Article : Google Scholar : PubMed/NCBI

Liu W, Lin S, Cai Q, Zhang L, Shen A, Chen Y and Peng J: Qingxuan Jiangya decoction mitigates renal interstitial fibrosis in spontaneously hypertensive rats by regulating transforming growth factor-β1/Smad signaling pathway. Evid Based Complement Alternat Med. 2017:15763282017. View Article : Google Scholar : PubMed/NCBI

Qin T, Wu L, Hua Q, Song Z, Pan Y and Liu T: Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation. J Ethnopharmacol. 246:1121282020. View Article : Google Scholar : PubMed/NCBI

Tian XL and Li Y: Endothelial cell senescence and age-related vascular diseases. J Genet Genomics. 41:485–495. 2014. View Article : Google Scholar : PubMed/NCBI

Regina C, Panatta E, Candi E, Melino G, Amelio I, Balistreri CR, Annicchiarico-Petruzzelli M, Di Daniele N and Ruvolo G: Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases. Mech Ageing Dev. 159:14–21. 2016. View Article : Google Scholar : PubMed/NCBI

Lankhorst S, Kappers MH, van Esch JH, Danser AH and van den Meiracker AH: Hypertension during vascular endothelial growth factor inhibition: Focus on nitric oxide, endothelin-1, and oxidative stress. Antioxid Redox Signal. 20:135–145. 2014. View Article : Google Scholar : PubMed/NCBI

Yang X, Shao H, Chen Y, Ding N, Yang A, Tian J and Jiang Y, Li G and Jiang Y: In renal hypertension, Cirsium japonicum strengthens cardiac function via the intermedin/nitric oxide pathway. Biomed Pharmacother. 101:787–791. 2018. View Article : Google Scholar : PubMed/NCBI

Yoshitomi H, Zhou J, Nishigaki T, Li W, Liu T, Wu L and Gao M: Morinda citrifolia (Noni) fruit juice promotes vascular endothelium function in hypertension via glucagon-like peptide-1 receptor-CaMKKβ-AMPK-eNOS pathway. Phytother Res. 34:2341–2350. 2020. View Article : Google Scholar : PubMed/NCBI

Razali N, Dewa A, Asmawi MZ, Mohamed N and Manshor NM: Mechanisms underlying the vascular relaxation activities of Zingiber officinale var. rubrum in thoracic aorta of spontaneously hypertensive rats. J Integr Med. 18:46–58. 2020. View Article : Google Scholar : PubMed/NCBI

Akinyemi AJ, Onyebueke N, Faboya OA, Onikanni SA, Fadaka A and Olayide I: Curcumin inhibits adenosine deaminase and arginase activities in cadmium-induced renal toxicity in rat kidney. J Food Drug Anal. 25:438–446. 2017. View Article : Google Scholar : PubMed/NCBI

Zhang DM, Li YC, Xu D, Ding XQ and Kong LD: Protection of curcumin against fructose-induced hyperuricaemia and renal endothelial dysfunction involves NO-mediated JAK-STAT signalling in rats. Food Chem. 134:2184–2193. 2012. View Article : Google Scholar : PubMed/NCBI

Tew WY, Tan CS, Asmawi MZ and Yam MF: Underlying mechanism of vasorelaxant effect exerted by 3,5,7,2′,4′-pentahydroxyflavone in rats aortic ring. Eur J Pharmacol. 880:1731232020. View Article : Google Scholar : PubMed/NCBI

Yang J, Wang R, Cheng X, Qu H, Qi J, Li D, Xing Y, Bai Y and Zheng X: The vascular dilatation induced by Hydroxysafflor yellow A (HSYA) on rat mesenteric artery through TRPV4-dependent calcium influx in endothelial cells. J Ethnopharmacol. 256:1127902020. View Article : Google Scholar : PubMed/NCBI

Xu J, Zhang C, Shi X, Li J, Liu M, Jiang W and Fang Z: Efficacy and safety of sodium tanshinone IIA sulfonate injection on hypertensive nephropathy: A systematic review and meta-analysis. Front Pharmacol. 10:15422019. View Article : Google Scholar : PubMed/NCBI

Li P, Peng Y, Ma Q, Li Z and Zhang X: Study on the formation of antihypertensive twin drugs by caffeic acid and ferulic acid with telmisartan. Drug Des Devel Ther. 14:977–992. 2020. View Article : Google Scholar : PubMed/NCBI

He F, Chu JF, Chen HW, Lin W, Lin S, Chen YQ, Peng J and Chen KJ: Qingxuan Jiangya decoction () prevents blood pressure elevation and ameliorates vascular structural remodeling via modulating TGF-β 1/Smad pathway in spontaneously hypertensive rats. Chin J Integr Med. 26:180–187. 2020. View Article : Google Scholar : PubMed/NCBI

Ye F, He J, Wu X, Xie J, Chen H, Tang X, Lai Z, Huang R and Huang J: The regulatory mechanisms of Yulangsan MHBFC reversing cardiac remodeling in rats based on eNOS-NO signaling pathway. Biomed Pharmacother. 117:1091412019. View Article : Google Scholar : PubMed/NCBI

Li W, Jiang YH, Wang Y, Zhao M, Hou GJ, Hu HZ and Zhou L: Protective effects of combination of radix astragali and radix salviae miltiorrhizae on kidney of spontaneously hypertensive rats and renal intrinsic cells. Chin J Integr Med. 26:46–53. 2020. View Article : Google Scholar : PubMed/NCBI

Ma C, Zhai C, Xu T, Lu F, Zhang S, Li C, Wang Q, Cheng F and Wang X: A systems pharmacology-based study of the molecular mechanisms of San Cao decoction for treating hypertension. Evid Based Complement Alternat Med. 2019:31714202019. View Article : Google Scholar : PubMed/NCBI

Tanaka M and Itoh H: Hypertension as a metabolic disorder and the novel role of the gut. Curr Hypertens Rep. 21:632019. View Article : Google Scholar : PubMed/NCBI

Hall JE, do Carmo JM, da Silva AA, Wang Z and Hall ME: Obesity, kidney dysfunction and hypertension: Mechanistic links. Nat Rev Nephrol. 15:367–385. 2019. View Article : Google Scholar : PubMed/NCBI

Bell DS: Treatment of diabetic hypertension. Diabetes Obes Metab. 11:433–444. 2009. View Article : Google Scholar : PubMed/NCBI

Busija DW, Miller AW, Katakam P and Erdös B: Insulin resistance and associated dysfunction of resistance vessels and arterial hypertension. Minerva Med. 96:223–232. 2005.PubMed/NCBI

Eringa EC, Bakker W and van Hinsbergh VW: Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vascul Pharmacol. 56:204–209. 2012. View Article : Google Scholar : PubMed/NCBI

Gamboa-Gómez C, Pérez-Ramírez IF, González-Gallardo A, Gallegos-Corona MA, Ibarra-Alvarado C and Reynoso-Camacho R: Effect of Citrus paradisi and Ocimum sanctum infusions on blood pressure regulation and its association with renal alterations in obese rats. J Food Biochem. 40:345–357. 2016. View Article : Google Scholar

Ren Y, Wang D, Lu F, Zou X, Xu L, Wang K, Huang W, Su H, Zhang C, Gao Y and Dong H: Coptidis rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy. Phytomedicine. 49:52–65. 2018. View Article : Google Scholar : PubMed/NCBI

Liu BL, Chen YP, Cheng H, Wang YY, Rui HL, Yang M, Dong HR, Han DN and Dong J: The protective effects of curcumin on obesity-related glomerulopathy are associated with inhibition of Wnt/β-catenin signaling activation in podocytes. Evid Based Complement Alternat Med. 2015:8274722015. View Article : Google Scholar : PubMed/NCBI

Ma L, Huang L, Pei H, Liu Z, Xie C, Lei L, Chen X, Ye H, Peng A and Chen L: Pharmacological effects of the water fraction of key components in the traditional Chinese prescription Mai Tong Fang on 3T3-L1 adipocytes and ob/ob diabetic mice. Molecules. 19:14687–14698. 2014. View Article : Google Scholar : PubMed/NCBI

Basile J and Toth P: Angiotensin receptor blockers: Role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med J. 102 (10 Suppl):S1–S12. 2009. View Article : Google Scholar : PubMed/NCBI

Pirkle JL and Freedman BI: Hypertension and chronic kidney disease: Controversies in pathogenesis and treatment. Minerva Urol Nefrol. 65:37–50. 2013.PubMed/NCBI

Yang C, Wang H, Zhao X, Matsushita K, Coresh J, Zhang L and Zhao MH: CKD in China: Evolving spectrum and public health implications. Am J Kidney Dis. 76:258–264. 2020. View Article : Google Scholar : PubMed/NCBI

Leong XF, Ng CY and Jaarin K: Animal models in cardiovascular research: Hypertension and atherosclerosis. Biomed Res Int. 2015:5287572015. View Article : Google Scholar : PubMed/NCBI

Meili-Butz S, Bühler K, John D, Buser P, Vale WW, Peterson KL, Brink M and Dieterle T: Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure. Eur J Heart Fail. 12:797–804. 2010. View Article : Google Scholar : PubMed/NCBI

Liu ML, Song HX, Tian XX, Liu YX, Liu D, Hou ZW, Li JY, Yan CH and Han YL: Recombinant cellular repressor of E1A-stimulated genes protects against renal fibrosis in Dahl salt-sensitive rats. Am J Nephrol. 51:401–410. 2020. View Article : Google Scholar : PubMed/NCBI

Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, Xie Z, Song P and Zou MH: Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun. 10:21452019. View Article : Google Scholar : PubMed/NCBI

Han WQ, Xu L, Tang XF, Chen WD, Wu YJ and Gao PJ: Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition. J Physiol. 596:3603–3616. 2018. View Article : Google Scholar : PubMed/NCBI

Su Y, Deng X, Ma R, Dong Z, Wang F and Shi J: The Exposure of phosphatidylserine influences procoagulant activity in retinal vein occlusion by microparticles, blood cells, and endothelium. Oxid Med Cell Longev. 2018:36584762018. View Article : Google Scholar : PubMed/NCBI